SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome
Christian Rosas-Salazar, Kyle S Kimura, Meghan H Shilts, Britton A Strickland, Michael H Freeman, Bronson C Wessinger, Veerain Gupta, Hunter M Brown, Seesandra V Rajagopala, Justin H Turner, Suman R Das, Christian Rosas-Salazar, Kyle S Kimura, Meghan H Shilts, Britton A Strickland, Michael H Freeman, Bronson C Wessinger, Veerain Gupta, Hunter M Brown, Seesandra V Rajagopala, Justin H Turner, Suman R Das
Abstract
Background: Little is known about the relationships between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the respiratory virus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic, and the upper respiratory tract (URT) microbiome.
Objective: We sought to compare the URT microbiome between SARS-CoV-2-infected and -uninfected adults and to examine the association of SARS-CoV-2 viral load with the URT microbiome during COVID-19.
Methods: We characterized the URT microbiome using 16S ribosomal RNA sequencing in 59 adults (38 with confirmed, symptomatic, mild to moderate COVID-19 and 21 asymptomatic, uninfected controls). In those with COVID-19, we measured SARS-CoV-2 viral load using quantitative reverse transcription PCR. We then examined the association of SARS-CoV-2 infection status and its viral load with the ⍺-diversity, β-diversity, and abundance of bacterial taxa of the URT microbiome. Our main models were all adjusted for age and sex.
Results: The observed species index was significantly higher in SARS-CoV-2-infected than in -uninfected adults (β linear regression coefficient = 7.53; 95% CI, 0.17-14.89; P = .045). In differential abundance testing, 9 amplicon sequence variants were significantly different in both of our comparisons, with Peptoniphilus lacrimalis, Campylobacter hominis, Prevotella 9 copri, and an Anaerococcus unclassified amplicon sequence variant being more abundant in those with SARS-CoV-2 infection and in those with high viral load during COVID-19, whereas Corynebacterium unclassified, Staphylococcus haemolyticus, Prevotella disiens, and 2 Corynebacterium_1 unclassified amplicon sequence variants were more abundant in those without SARS-CoV-2 infection and in those with low viral load during COVID-19.
Conclusions: Our findings suggest complex associations between SARS-CoV-2 and the URT microbiome in adults. Future studies are needed to examine how these viral-bacterial interactions can impact the clinical progression, severity, and recovery of COVID-19.
Keywords: 16S rRNA sequencing; COVID-19; SARS-CoV-2; coronavirus; microbiome; nasal; nasopharynx; respiratory.
Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Figures
References
- Man W.H., de Steenhuijsen Piters W.A., Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15:259–270.
- Ederveen T.H.A., Ferwerda G., Ahout I.M., Vissers M., de Groot R., Boekhorst J. Haemophilus is overrepresented in the nasopharynx of infants hospitalized with RSV infection and associated with increased viral load and enhanced mucosal CXCL8 responses. Microbiome. 2018;6:10.
- de Steenhuijsen Piters W.A., Heinonen S., Hasrat R., Bunsow E., Smith B., Suarez-Arrabal M.C. Nasopharyngeal microbiota, host transcriptome, and disease severity in children with respiratory syncytial virus infection. Am J Respir Crit Care Med. 2016;194:1104–1115.
- Sonawane A.R., Tian L., Chu C.Y., Qiu X., Wang L., Holden-Wiltse J. Microbiome-transcriptome interactions related to severity of respiratory syncytial virus infection. Sci Rep. 2019;9:13824.
- Rosas-Salazar C., Shilts M.H., Tovchigrechko A., Schobel S., Chappell J.D., Larkin E.K. Nasopharyngeal lactobacillus is associated with childhood wheezing illnesses following respiratory syncytial virus infection in infancy. J Allergy Clin Immunol. 2018;142:1447–1456.
- Shilts MH, Rosas-Salazar C, Turi KN, Rajan D, Rajagopala SV, Patterson MF, et al. Nasopharyngeal haemophilus and local immune response during infant respiratory syncytial virus infection [published online ahead of print July 3, 2020]. J Allergy Clin Immunol. .
- Liu Y., Yan L.M., Wan L., Xiang T.X., Le A., Liu J.M. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20:656–657.
- Pujadas E., Chaudhry F., McBride R., Richter F., Zhao S., Wajnberg A. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020;8:e70.
- World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. Available at: . Accessed February 23, 2021.
- Kimura K.S., Freeman M.H., Wessinger B.C., Gupta V., Sheng Q., Huang L.C. Interim analysis of an open-label randomized controlled trial evaluating nasal irrigations in non-hospitalized patients with COVID-19. Int Forum Allergy Rhinol. 2020;10:1325–1328.
- Singh K., Gobert A.P., Coburn L.A., Barry D.P., Allaman M., Asim M. Dietary arginine regulates severity of experimental colitis and affects the colonic microbiome. Front Cell Infect Microbiol. 2019;9:66.
- Hiremath G., Shilts M.H., Boone H.H., Correa H., Acra S., Tovchigrechko A. The salivary microbiome is altered in children with eosinophilic esophagitis and correlates with disease activity. Clin Transl Gastroenterol. 2019;10
- Kozich J.J., Westcott S.L., Baxter N.T., Highlander S.K., Schloss P.D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79:5112–5120.
- Oksanen J., Blanchet F.G., Kindt R., Legendre P., Minchin P.R., O’Hara R.B. vegan: Community Ecology Package. 2014. Available at: Accessed December 15, 2020.
- Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
- De Maio F., Posteraro B., Ponziani F.R., Cattani P., Gasbarrini A., Sanguinetti M. Nasopharyngeal microbiota profiling of SARS-CoV-2 infected patients. Biol Proced Online. 2020;22:18.
- Zhang H, Ai JW, Yang W, Zhou X, He F, Xie S, et al. Metatranscriptomic characterization of COVID-19 identified a host transcriptional classifier associated with immune signaling [published online ahead of print May 28, 2020]. Clin Infect Dis. .
- Shen Z., Xiao Y., Kang L., Ma W., Shi L., Zhang L. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin Infect Dis. 2020;71:713–720.
- Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266–275.
- Fan J., Li X., Gao Y., Zhou J., Wang S., Huang B. The lung tissue microbiota features of 20 deceased patients with COVID-19. J Infect. 2020;81:e64–e67.
- Campanella T. COVID-19 complicates an already difficult presentation of infective endocarditis. Contagion Live.
- Gu S., Chen Y., Wu Z., Chen Y., Gao H., Lv L. Alterations of the gut microbiota in patients with COVID-19 or H1N1 influenza. Clin Infect Dis. 2020;5
- Rosas-Salazar C., Shilts M.H., Tovchigrechko A., Schobel S., Chappell J.D., Larkin E.K. Differences in the nasopharyngeal microbiome during acute respiratory tract infection with human rhinovirus and respiratory syncytial virus in infancy. J Infect Dis. 2016;214:1924–1928.
- Kim D., Quinn J., Pinsky B., Shah N.H., Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085–2086.
- Sungnak W., Huang N., Becavin C., Berg M., Queen R., Litvinukova M. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26:681–687.
- Kimura K.S., Freeman M.H., Wessinger B.C., Gupta V., Sheng Q., Huang L.C. Interim analysis of an open-label randomized controlled trial evaluating nasal irrigations in non-hospitalized patients with COVID-19. Int Forum Allergy Rhinol. 2020;10:1325–1328.
- World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization. Available at: . Accessed February 23, 2021.
- Centers for Disease Control and Prevention . 2020. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel. Available at: . Accessed December 15, 2020.
- Singh K., Gobert A.P., Coburn L.A., Barry D.P., Allaman M., Asim M. Dietary arginine regulates severity of experimental colitis and affects the colonic microbiome. Front Cell Infect Microbiol. 2019;9:66.
- Hiremath G., Shilts M.H., Boone H.H., Correa H., Acra S., Tovchigrechko A. The salivary microbiome is altered in children with eosinophilic esophagitis and correlates with disease activity. Clin Transl Gastroenterol. 2019;10
- Kozich J.J., Westcott S.L., Baxter N.T., Highlander S.K., Schloss P.D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79:5112–5120.
- Callahan B.J., McMurdie P.J., Rosen M.J., Han A.W., Johnson A.J., Holmes S.P. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13:581–583.
- Pruesse E., Quast C., Knittel K., Fuchs B.M., Ludwig W., Peplies J. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007;35:7188–7196.
- Davis N.M., Proctor D.M., Holmes S.P., Relman D.A., Callahan B.J. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6:226.
- McMurdie P.J., Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013;8
- R Development Core Team . R Foundation for Statistical Computing; Vienna, Austria: 2006. R: a language and environment for statistical computing.
- Anderson M.J. A new method for non-parametric multivariate analysis of variance. Austral Ecol. 2001;26:32–46.
- Oksanen J., Blanchet F.G., Kindt R., Legendre P., Minchin P.R., O’Hara R.B. vegan: Community Ecology Package. 2014. Available at: Accessed December 15, 2020.
- Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
- Benjamini Y., Hochberg Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. J Royal Stat Soc Series B-Methodol. 1995;57:289–300.
Source: PubMed